Skip to content

Penumbra PEN Common Stock

Common Stock at other companies

Stryker logo
StrykerSYK
$38M0.0%
Medtronic logo
MedtronicMDT
$0

Other financials

Income statement

See full
Revenue$374.8M+15.6%
Gross profit$253.4M+17.4%
Operating income$38.2M-5.2%
Net income$32.6M-16.9%
EPS (diluted)$0.82-18.0%

Balance sheet

See full
Cash & equivalents$241.3M-35.8%
Total debt$216.2M-2.0%
Total equity$1.5B+21.5%
Total assets$1.9B+19.2%

Cash flow

See full
Operating cash flow$87.0M+77.6%
CapEx$13.7M+1.5%
Free cash flow$73.3M+106%

Valuation

See full
Market cap$12.48B+25.1%
Enterprise value$12.45B+26.8%
P/E72.9×-163×
P/S8.6×+0.5×

Profitability

See full
Gross margin67.4%+3.7pp
Operating margin12.9%+9.8pp
Net margin11.8%+8.4pp
FCF margin14.6%+2.5pp

Returns & leverage

See full
Return on equity12.7%+9.2pp
Debt / equity0.1×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Penumbra in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Penumbra’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Penumbra's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Penumbra's common stock?
Penumbra (PEN) reported common stock of $39K in Q1 2026.
How has Penumbra's common stock changed year-over-year?
Penumbra's common stock decreased by 0.0% year-over-year, from $39K to $39K.
What is the long-term trend for Penumbra's common stock?
Over 5 years (2020 to 2025), Penumbra's common stock has grown at a 1.6% compound annual growth rate (CAGR), from $36K to $39K.
What does common stock mean?
The par value of the company's issued common equity shares.
How do you interpret common stock?
Changes in this value typically reflect share issuances or buybacks, impacting the company's capital structure and shareholder dilution.
How does common stock compare across companies?
Common stock par values are generally nominal across the industry, with most equity value residing in additional paid-in capital.